US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-21 17:37:29 Source：Culture Craft news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：Who is Jacob Zuma, the former South African president disqualified from next week's election?
- Next：'The Apprentice,' about a young Donald Trump, premieres in Cannes
Related articles
- Analysis: Larson enters conversation with Verstappen as best drivers in the world
- Chinese business group slams EU probe into trainmaker
- Index reflects nation's strength in AI governance
- EU set to fine Apple $540 mln for unfair play
- Iran helicopter crash that killed President Raisi could reverberate across the Middle East
- China's internet sector R&D spending logs robust growth in Jan.
- China now S. Korea's top e
- Models of China's space station and lunar rover Yutu displayed in Vienna
- Saudi Arabia is going to sponsor the WTA women's tennis rankings under a new partnership
- Explainer: Payment service guide for overseas visitors to China
- Brazil replaces injured goalkeeper Ederson in Copa America squad
- 2022 World Internet Conference Wuzhen Summit sees record participants
- Over 5 bln USD of tentative deals inked at east China digital trade expo
- China now S. Korea's top e
- Inquiry slams UK authorities for failures that killed thousands in infected blood scandal
- China's non
- Peng Liyuan Attends UNESCO Award Ceremony for Girls', Women's Education
- Explainer: Payment service guide for overseas visitors to China
- Supreme Court rejects an appeal from a Canadian man once held at Guantanamo
- Tourism industry hits record highs over Spring Festival holiday
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Culture Craft news portal sitemap